Aim: To report efficacy and safety measures for XEN45 in a National Health Service setting after 24-month follow-up.
Methods: This is a retrospective, non-comparative audit of records of patients who underwent XEN45 procedure between June 2015 and May 2017. The main outcome measures were intraocular pressure (IOP) reduction and number of antihypertensive medications at each timepoint.